Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Unsupervised Therapy After Stroke in the Home Setting With a Hand Rehabilitation Device (ReHandyBot): an Exploratory Study

NCT06057129 is registered in ClinicalTrials.gov with Swiss Federal Institute of Technology as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06057129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Unsupervised Therapy After Stroke in the Home Setting With a Hand Rehabilitation Device (ReHandyBot): an Exploratory Study
Lead sponsor
Swiss Federal Institute of Technology
Phase
Not applicable
Overall status
Completed
Start date
November 13, 2023
Completion date
May 29, 2026
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.